The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
96709372 9670937 2 F 20121115 20140618 20131106 20160714 EXP KR-JNJFOC-20131017674 JANSSEN 29.14 YR A F Y 0.00000 20160712 MD KR KR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
96709372 9670937 1 SS STELARA USTEKINUMAB 1 Subcutaneous N 0 45 MG SOLUTION FOR INJECTION
96709372 9670937 2 SS STELARA USTEKINUMAB 1 Subcutaneous N 0 45 MG SOLUTION FOR INJECTION
96709372 9670937 3 SS STELARA USTEKINUMAB 1 Subcutaneous N 0 45 MG SOLUTION FOR INJECTION
96709372 9670937 4 SS STELARA USTEKINUMAB 1 Subcutaneous N 0 45 MG SOLUTION FOR INJECTION
96709372 9670937 5 PS STELARA USTEKINUMAB 1 Subcutaneous N 125261 45 MG SOLUTION FOR INJECTION
96709372 9670937 6 C METOJECT METHOTREXATE SODIUM 1 Subcutaneous 0 15 MG UNSPECIFIED
96709372 9670937 7 C METOJECT METHOTREXATE SODIUM 1 Subcutaneous 0 16 MG UNSPECIFIED
96709372 9670937 8 C ELIDEL PIMECROLIMUS 1 Unknown 0 OINTMENT
96709372 9670937 9 C DAIVOBET BETAMETHASONE DIPROPIONATECALCIPOTRIENE 1 Unknown 0 OINTMENT
96709372 9670937 10 C SULFASALAZINE DELAYED-RELEASE SULFASALAZINE 1 Unknown 0 500 MG TABLET QOD
96709372 9670937 11 C MYPOL 2 Unknown 0 CAPSULE
96709372 9670937 12 C MYPOL 2 Unknown 0 CAPSULE
96709372 9670937 13 C MYPOL 2 Unknown 0 CAPSULE
96709372 9670937 14 C MYPOL 2 Unknown 0 CAPSULE
96709372 9670937 15 C ULTRACET ACETAMINOPHENTRAMADOL HYDROCHLORIDE 1 Unknown 0 TABLET
96709372 9670937 16 C AIRTAL ACECLOFENAC 1 Unknown 0 TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
96709372 9670937 1 Psoriasis
96709372 9670937 2 Psoriasis
96709372 9670937 3 Psoriasis
96709372 9670937 4 Psoriasis
96709372 9670937 5 Psoriasis
96709372 9670937 6 Psoriasis
96709372 9670937 7 Psoriasis
96709372 9670937 8 Psoriasis
96709372 9670937 9 Psoriasis
96709372 9670937 10 Psoriasis
96709372 9670937 11 Analgesic therapy
96709372 9670937 12 Analgesic therapy
96709372 9670937 13 Analgesic therapy
96709372 9670937 14 Analgesic therapy
96709372 9670937 15 Analgesic therapy
96709372 9670937 16 Analgesic therapy

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
96709372 9670937 Liver function test abnormal

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
96709372 9670937 1 20130509 20130509 0
96709372 9670937 2 20130814 20131120 0
96709372 9670937 3 20130214 20130214 0
96709372 9670937 4 20121115 20121115 0
96709372 9670937 5 20121018 20121018 0
96709372 9670937 6 20130404 20130523 0
96709372 9670937 7 20120725 20121108 0
96709372 9670937 8 20121115 20121122 0
96709372 9670937 9 20120718 0
96709372 9670937 10 20130214 0
96709372 9670937 11 20120913 20120920 0
96709372 9670937 12 20131120 20131127 0
96709372 9670937 13 20130902 20130909 0
96709372 9670937 14 20130509 20130516 0
96709372 9670937 15 20120913 20121115 0
96709372 9670937 16 20121122 0